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Bone loss markers in the earliest 
Pacific Islanders
Justyna J. Miszkiewicz 1*, Frédérique Valentin2,3, Christina Vrahnas4,5,6, Natalie A. Sims5,6, 
Jitraporn Vongsvivut7, Mark J. Tobin7 & Geoffrey Clark3
Kingdom of Tonga in Polynesia is one of the most obese nations where metabolic conditions, 
sedentary lifestyles, and poor quality diet are widespread. These factors can lead to poor 
musculoskeletal health. However, whether metabolic abnormalities such as osteoporosis occurred 
in archaeological populations of Tonga is unknown. We employed a microscopic investigation of 
femur samples to establish whether bone loss afflicted humans in this Pacific region approximately 
3000 years ago. Histology, laser confocal microscopy, and synchrotron Fourier-transform infrared 
microspectroscopy were used to measure bone vascular canal densities, bone porosity, and carbonate 
and phosphate content of bone composition in eight samples extracted from adult Talasiu males and 
females dated to 2650 BP. Compared to males, samples from females had fewer vascular canals, lower 
carbonate and phosphate content, and higher bone porosity. Although both sexes showed evidence of 
trabecularised cortical bone, it was more widespread in females (35.5%) than males (15.8%). Our data 
suggest experiences of advanced bone resorption, possibly as a result of osteoporosis. This provides 
first evidence for microscopic bone loss in a sample of archaeological humans from a Pacific population 
widely afflicted by metabolic conditions today.
The global obesity pandemic is increasing at an alarming rate posing growing health concerns and an economic 
burden for human generations today and in the  future1. In 2019, the cost of treating obesity was estimated at 
USD $2 trillion (~ 2.8% of gross domestic product globally), with 9% of world population considered obese, 
and a further 392 million of youth predicted to become overweight or obese by  20251,2. Human populations in 
the Pacific Islands are consistently classified as some of the world’s most obese  nations3. The Kingdom of Tonga 
in Polynesia, in particular, has one of the largest prevalence in type 2  diabetes4. The reasons behind such high 
prevalence of metabolic conditions across the Pacific are complex. Studies have identified hereditary  factors3,5 
and environmental constraints that interplay with genetics, individual lifestyle, and access to  resources6,7. While 
modern sedentary lifestyle is understood to underlie many metabolic  conditions8, shedding light on the roots 
of these conditions can be predominantly achieved by examining health and disease markers left on human 
remains in the archaeological  record9,10. Prior research examining the surviving skeletons of archaeological Pacific 
Islanders reported possible evidence of diseases such as  gout11 and Forestier’s disease (diffuse idiopathic skeletal 
hyperostosis—DISH)12 in ca. 3,000‐year‐old Vanuatu. Both diseases occur in the same populations  today13, which 
suggests that the origins of these cannot be completely modern. Therefore, the study of archaeological human 
skeletal remains has the potential to fundamentally shift our understanding of the origins, or at least continuity 
in occurrence, of modern health  problems14,15.
Obesity is typically associated with physical inactivity and nutrition of poor  quality16. Both factors can have 
detrimental effects on bone physiology and structure because of a minimised mechanical loading  regime17 and 
restricted dietary calcium and vitamin  consumption18,19, which can lead to an increase in bone turnover where 
bone loss dominates bone  gain18. This advances bone tissue age and can result in greater fragility, susceptibility 
to fractures, and a diagnosis of osteopenia or  osteoporosis19. The deteriorating bone microarchitecture is caused 
by a shift in the activity balance between cells that normally renew the skeleton by bone remodelling such that 
osteoclast-mediated bone resorption exceeds bone deposition by  osteoblasts20,21. Continuing bone loss in such 
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fragile bones of individuals, particularly the elderly, with untreated osteoporosis impairs lifestyle and mobility 
as fractures occur repeatedly or heal poorly. Osteoporosis is common in modern aging populations, and as such 
poses a large economic burden. The condition is known as the “silent disease” manifesting only once fracture 
has  occurred22–24. The difficulty in completely preventing osteoporosis lies in its multi-factorial and inter-linked 
aetiology. Osteoporosis, meaning ‘porous bones’, can take different forms (e.g. primary or secondary) and as 
such develops as a result of various factors including  ageing25, female biological  sex26, lack of physical  activity27, 
genetic  predisposition28, hormone  deficiencies29, dietary  restrictions18,19, including those resulting from psychi-
atric conditions such as anorexia  nervosa30, and a combination of these and other variables that can relate to 
socio-economic  status14,15. The effect of sex on bone health has been particularly well studied in post-menopausal 
women, where loss of oestrogen, a hormone essential in inhibiting bone resorption, is a causative  factor31,32.
There has been much discussion about the relationship between obesity and  osteoporosis33–36. Not only 
does a lack of exercise negatively impact bone density, a cell based link between fat and bone tissue has been 
 proposed37. As bone loss increases with age, the number of bone marrow fat cells (adipocytes)  rises37. Bone-
forming osteoblasts and fat cells differentiate from the same bone-marrow precursor cells, yet whether bone 
loss is a precursor to fat infiltration or vice versa remains a point of  contention37. To complicate matters further, 
a heavier frame can have a positive effect on bone formation due to the higher weight-bearing from increased 
body mass—a relationship which has been termed the “obesity paradox”35,36. The development of osteoporotic 
bone in obese patients has been demonstrated in clinical studies, though data have not been  consistent38–40. For 
example, some sites of the skeleton, such as vertebrae, but not the hip, have been classified as osteoporotic in obese 
or overweight  individuals39. Obesity incidence has been reported in  Tonga4, but osteoporosis data are extremely 
limited. Reports from the past two decades paint a conflicting picture. In 2006, Tonga (included amongst other 
countries from the “Western Pacific”) was ranked second highest, after Europe, for prevalence of osteoporotic 
 fractures41. In contrast, “the Polynesian bone phenotype” has been characterised as having higher bone density 
than that of European  counterparts42. The International Osteoporosis Foundation is yet to map fracture inci-
dence across the Pacific Islands  comprehensively43. The efficiency of data collection there is possibly hindered 
by limited radiography  infrastructure42.
Clinically, osteoporosis in modern populations is diagnosed from measures of bone mineral density (BMD) 
and occurrence of  fractures44–46. Whether an individual suffers from abnormal bone fragility defined as osteo-
penia or osteoporosis is diagnosed from BMD T-scores that are lower than those of healthy age-matched 
 cohorts47. A gold standard methodology to collect BMD in living people is dual energy x-ray absorptiom-
etry (bone densitometry, DXA)48. Diagnosis can be supplemented through bone turnover markers from bone 
 histomorphometry49, or quantitative ultrasound  techniques50, and various other types of microscopy that measure 
bone porosity two- (2D) or three- (3D)  dimensionally51.
Similar means have been implemented to confirm the incidence of possible osteoporosis in various archaeo-
logical  European52–57, North  American58, and  African59–61 osteological collections (see  reviews15,62–64). Where 
access to large and well-preserved specimens has been possible, DXA, cortical and/or trabecular bone volume, 
and bone turnover assessment methods have indicated significant bone  loss52–55,60,65–67. Analyses of fracture types 
and their patterns (such as classic Colles’ fractures) have also provided insights into archaeological experiences of 
 osteoporosis66–69. Microscopic methods reconstructing bone turnover, mineral composition, and trabecular and 
cortical bone microarchitecture in archaeological human remains have also been  successful70–72. Non-invasive 
approaches such as 3D micro-computed tomography (micro-CT) can help in the calculation of trabecular or 
cortical bone thickness, separation, and the visualisation of porosity  network73,74. Invasive methods such as histol-
ogy rely on an extraction of samples to describe more localised bone  changes72,75. Therefore, invasive techniques 
are less often applied to archaeological samples because of the irreplaceable nature of excavated  remains76, and 
so typically rely on smaller sample  sizes77. Additionally, preservation issues (such as degradation of bone micro-
structure post-mortem78) can further limit the application of modern clinical osteoporosis diagnostic criteria to 
archaeological  remains71,79. Therefore, while the examination of disease in archaeological remains can provide 
fruitful results, response of living bone to disease cannot be observed. However, a combination of different 
methods can provide multiple lines of data for differential diagnosis and interpretation.
To the best of our knowledge, bone loss as a result of possible osteoporosis has not yet been investigated in 
archaeological samples in the Pacific. Obesity specifically as a factor leading to osteoporosis cannot be directly 
reconstructed for archaeological specimens as the available methods of body mass estimation still provide large 
 error80. However, given the widespread health issues in contemporary Pacific nations, bone loss markers in 
archaeological human remains in this region could be an indicator of musculoskeletal health and metabolic issues 
similar to those seen there today. The 2,650 BP archaeological site of Talasiu in the Kingdom of Tonga is one of 
the most significant sites ever uncovered in the  Pacific81,82. This site has previously produced the first evidence 
for Early Polynesian mortuary  behaviour81,82, archaeological Polynesian diet relying on marine  resources83, and 
insights into the abandonment of ceramics by early Polynesian  people84. We set out to test whether archaeologi-
cal Tongan human bone would show evidence of abnormal bone loss marked by sex-specific differences. We 
employed an invasive microscopic examination to characterise bone metabolic fluctuations in eight samples 
extracted from femora in the Talasiu individuals, sub-divided into groups of estimated sex (four males, four 
females). All individuals were classified as ‘adults’ who likely lived beyond 30 years of age, which means their 
bone tissue had entered an age-driven degeneration phase following a peak bone mass accrual point of lifespan. 
One female (ID: Sk3.1) was possibly an elderly individual (Table S1), who might have survived into a sixth life 
decade and possibly beyond. We used several microscopic methods to provide multiple lines of data. We recorded 
sexually dimorphic femur size differences, and then combined 2D  histology75,85, 3D laser scanning confocal 
 microscopy51, and synchrotron particle accelerator methods (Fourier-transform infrared microspectroscopy, 
sFTIRM)86,87 (Fig. 1). This allowed us to examine compact femur bone Haversian canal densities as a proxy for 
remodelling (Fig. 2), abnormal porosity as a marker of prolonged bone resorption (Figs. 2, 3), and bone matrix 
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composition through carbonate and phosphate content (Fig. 1), averages of which we hypothesised to differ 
between the estimated female and male sex groups.
Results
We found evidence for bone loss, which differed between the estimated sex groups in our samples. Porosity which 
manifested as cortical bone trabecularisation was particularly advanced in the females. As expected, due to sexual 
dimorphism, males in our sample had larger femora when compared to the females (Table 1, Fig. 1). The average 
midshaft circumference was 92.25 mm (standard deviation (SD) = 4.79) in males, but 79.75 mm (SD = 7.09) in 
females (U = 15.5; p = 0.029). The diameter of femur midshaft was also larger and more pronounced in males in 
both the antero-posterior (A-P), and medio-lateral (M-L) planes. The A-P diameter was 30.75 mm (SD = 2.87) 
in males, but 27.26 mm (SD = 2.15) in females, albeit this difference was not statistically significant.
The sexual dimorphism was likely also reflected in the 2D histological measurements of bone Haversian 
canal density collected from the cortical area of bone unaffected by porosity producing trabecularisation, which 
was higher in males (17.445/mm2) than in females (15.603/mm2) (Table 1, S2; Figs. 1, 2, 4). However, the area 
of bone samples showing porosity producing trabecularisation which represented as ‘giant’ coalescing pores 
was more evident in females than in males (Fig. 1). The average porosity producing trabecularisation was 35.5% 
(SD = 16.40) in females, but only 15.8% (SD = 24.17) in males. In fact, all four female samples were affected 
by a high degree of porosity producing trabecularisation that was widespread from the most inner bone layer 
(endo-cortical) through the mid-section region (intra-cortical), reaching the bone areas immediate to the most 
outer bone layer (periosteum) (Figs. 1, 2). This led to cortical wall  thinning88, 89 and was a consistent pattern 
throughout the sample as supported by a statistically significant negative correlation between percent areas of 
trabecularisation and cortical wall area (Rho = − 0.762, p = 0.028; Fig. 5). However, comparing only the porosity 
and Haversian canal variables between the two sex groups did not result in statistical significance as males were 
clearly impacted by intra-cortical trabecularisation as well. In fact, one of the male samples (ID: Sk9.3, Figure S1) 
showed an estimated 51.8% of trabecularisation of intra-cortical bone. This data point is maximum across our 
entire sample of eight bones. The remaining three male samples showed an overall consistent appearance of 
porosity whereby the bone surfaces were dense, showing a limited range of variably sized porosity regions and 
their occurrence (one complete absence, Figs. 1, 3). On the contrary, the female samples exhibited much more 
Figure 1.  Summary of methods and key findings in the present study. Posterior view of two right archaeological 
femora from Talasiu individuals estimated as female (♀, ID: Sk3.1) and male (♂, ID: Sk3.2) shows the sectioning 
location (black dashed line) and approximate sample removed (red dashed box). Methodological steps included 
synchrotron sourced infrared microspectroscopy to measure bone mineral composition, histomorphometry 
to estimate Haversian canal densities (red dots), and laser confocal scanning of bone topography to provide a 
qualitative illustration of intra-cortical bone porosity producing trabecularisation.
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variability in porosity producing trabecularisation (Table 1, S2; Figs. 1, 2), ranging from 13.9% minimum to 
50.2% maximum of cortical bone space. The 3D confocal laser scans of bone surfaces from two cases showing 
extremes in bone micro-organisation (one female Sk3.1, one male Sk3.2) (Figs. 1, 3, S10, S11) demonstrated an 
almost entirely limited topography in the male sample, but more variable topography in the female sample which 
was punctuated with relatively deep and ‘giant pores’ the bone cortex.
The bone carbonate and phosphate content measured through sFTIRM was consistently lower in females 
(Figs. 4, 5; Table 2, S3–S6) (p < 0.05 in all sFTIRM variables except for integrated phosphate area). The aver-
age peak height of phosphate (from 848 spectra; U = 1,118,955.000; p < 0.013), and v2 (from 1676 spectra; 
U = 3,767,893.000; p < 0.0001) and v3 carbonates (from 2159 spectra; U = 4,978,269.000; p < 0.0001) were lower 
in females. While the phosphate difference of 2.6% in the means seems marginal, it was more substantial when 
considering v2 (30.3%) and v3 (32%) carbonates. We note that more spectra were successfully measured in the 
samples from males (2496 phosphate spectra, minimum 3329 v2 and 3264 v3 spectra) (Table 2, S3–S5). Com-
pared to the male samples, the average integrated areas of phosphate and two carbonate peaks were also lower 
in females. The phosphate area in females was only lower by 1.1% (Table S3). However, the v2 (U = 3,765,291.500; 
Figure 2.  A summary of histomorphometric procedures for estimating densities of Haversian canals and 
abnormal intra-cortical bone porosity. (a, b): localised histology (60 ×) viewed under linearly polarised light 
showing secondary osteon lamellae (white arrows) surrounding Haversian canals (oval features), which were 
obscured by patches of diagenesis (grey arrows). Cement lines (black arrow in b) were inconsistently preserved 
(examples shown are from individuals BG2 (a) and Sk9.3 (b). Haversian canals were counted manually form 
thresholded images (c–f): (c) shows numbered canals, (d) shows manual segmentation of cortical wall from 
abnormal intra-cortical porosity (red dashed line), while the solid line marks whole section area in individual 
BG2; (e) illustrates final counts of Haversian canals, while (f) shows ‘extracted’ abnormal bone porosity.
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p < 0.0001); and v3 (U = 4,847,614.000; p < 0.0001) carbonates were 35.3% and 44.12% greater in the samples from 
males (Table S4, S5). The carbonate v2:phosphate integrated area ratios from the female samples were lower by 
5% when compared to males (U = 1,421,109.000; p < 0.0001; Table S6). This was despite females recording a 
maximum ratio spectrum of 0.143 contrasted with a much lower maximum spectrum of 0.038 in males, and the 
higher total number of spectra collected in males (2495) contrasted with 846 spectra in females.
Discussion
We report the first microscopic record of bone loss characteristics in archaeological femora representing some 
of the earliest Pacific Islanders. On the basis of how commonplace contemporary metabolic issues, including 
obesity and diabetes, are in Tonga, we interpret our evidence to indicate that similar problems that might have led 
to osteoporosis occurred there ca. 3000 years ago. Two key implications are presented. Firstly, our small sample 
of archaeological humans from the Pacific appears to be afflicted by cortical bone porosity producing trabecu-
larisation despite the notion that osteoporosis and related conditions are modern-day diseases. This confirms 
that the occurrence of widespread metabolic disease in this region today may have roots in the past. It agrees 
with bone loss experiences reported for archaeological collections from around the world (see  reviews15,62–64), 
Figure 3.  Intra-cortical surfaces scanned using a three-dimensional laser confocal topography microscope 
Olympus OLS5000 with applied false-coloured heat map to illustrate extreme differences in porosity in 
archaeological posterior midshaft femur samples from Talasiu individuals estimated as female (♀, ID: Sk3.1) 
and male (♂, ID: Sk3.2). (a) shows topography viewed superiorly from the bone surface, whereas (b) is reverted 
upside down to show the inferior view of the same scan as (a).
Table 1.  Sample details and raw gross morphometric data of the femora representing adult archaeological 
males and females from Talasiu, Tongatapu, Kingdom of Tonga. Cortical width and midshaft circumference are 
reported in mm. A-P: antero-posterior, M-L: medio-lateral, H.Dn: Haversian canal density per  mm2, %Po.Ar: 
percent of sample impacted by porosity producing trabecularisation. *left femur, **probable sex.





A–P M–L H.Dn %Po.Ar
BG2 Female 25.28 23.35 76 22.223 31.890
Sk3.1 Female 28.93 24.87 86 13.159 50.232
Sk3.2 Male 33.87 29.27 101 15.627 7.261
Sk5 Male 27.72 22.17 86 20.798 0.000
Sk9.2* Female** 29.30 26.54 81 14.815 46.001
Sk9.3 Male** 29.00 27.34 87 16.530 51.793
Sk12 Female** 25.54 23.26 76 12.216 13.908
Sk14 Male 32.41 26.92 95 16.826 4.197
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and archaeological metabolic bone disease indicators reported in other parts of the  Pacific11,12. Secondly, the 
extensive cortical bone porosity leading to trabecularisation in our sample of archaeological Tongan females 
suggests experiences of oestrogen loss, mirroring modern day female osteoporosis incidence. This may further 
suggest at least the females represented in our sample lived to menopause age. The occurrence of trabecularisation 
in some of the male samples further points to advanced age despite widely held assumptions that past human 
longevity was shorter than today. We are unable to ascertain that archaeological Tongans specifically suffered 
from obesity, but we explain our findings through a differential diagnosis considering various aetiologies that 
might have impacted these individuals—complementarily or in an alternate fashion.
Occurrence of metabolic abnormalities as a result of lifestyle and environmental factors. The 
examination of human remains from archaeological backgrounds, such as tracing the origins of tuberculosis 
or  leprosy90, has revolutionised our current understanding of disease in the modern world. Osteoporosis is 
often considered a modern disease because it mostly manifests in the elderly and is strongly linked to modern 
sedentary lifestyles. However, its incidence was previously confirmed in various archaeological  European52–57, 
North  American58, and  African59–61 osteological assemblages. We now report the first microscopic record of 
abnormally porous human bones from the Pacific region, adding to the growing body of evidence that modern 
metabolic conditions in the Pacific may be rooted in the  past11,12.
Talasiu people are some of the earliest representatives of the Polynesian society emerging after the first set-
tlement of archipelago at c. 2850 cal  BP84. The estimated Tongan skeletal fragility presented here is consistent 
with a historic basis for other current highly prevalent widespread metabolic problems such as obesity and type 
Figure 4.  Graphical summary of results illustrating descriptive comparisons of data between archaeological 
Tongan individuals of estimated male (♂) and female (♀) sex. The boxplots indicate that females present with: 
(a) smaller femoral midshaft (dm: diameter), with lower Haversian canal density (per  mm2), but higher intra-
cortical porosity producing trabecularisation (%); (b, c) lower phosphate content; and (d–f) lower carbonate, 
and carbonate:phosphate ratios. Outliers are marked by asterisks and circles. *p < 0.05; ***p < 0.0001.
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2 diabetes in the  region3–5. Published evidence also exists for other types of skeletal abnormalities reported 
from different archaeological sites in  Tonga91–94, and  Vanuatu11,12,95. For example, scurvy and hypervitaminosis 
A, and iron-deficiency anaemia were discussed amongst several possible conditions arising in archaeological 
Tongan communities possibly as a result of poor  nutrition91. This came from skeletal evidence in 17 children 
aged 6 months to 3 years old suggesting a combination of infections and metabolic bone disease at the ’Atele 
pre-European burial mounds dated to AD 1100–1250 from Western  Tonga91. Further, poorly mineralised 21 
archaeological deciduous teeth obtained from infant skeletons excavated at ‘Atele in Tonga also indicated devel-
opmental disturbances in dental enamel linked to physiological stress arising from possible infections and nutri-
tional  deficiencies92. Stable isotope data extracted from archaeological human Tongan bone suggested diets to 
be predominantly based on starchy and marine food  sources83,93. Selection of a wider variety of food sources 
would have been limited by the island size in addition to norms arising from social  organisation83. Another site in 
Tonga, ca. 750–150 BP To-At-36 at Ha ‘ateiho, yielded examples of dental developmental disturbance and growth 
Figure 5.  Statistically significant Mann Whitney U ranking comparisons of the sFTIRM data for phosphate 
peaks (a), carbonate peaks and integrated area (b–e), and ratios computed using carbonate v2: phosphate area 
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disruption indicators in 33 adult and 11  juveniles94. Lower spine degeneration (spondylosis) was also observed 
on archaeological Tongan lumbar  vertebrae94. While spondylosis occurring as a result of bone degeneration due 
to age can be accelerated through weight bearing from active  lifestyles94 (combat sports at archaeological Tonga 
mounds were previously also  discussed96, and see our next discussion section about physical activity links to 
age-related bone loss), clinical studies have also linked it to increased body weight in  obesity97. The experiences 
of degenerative bone conditions in our sample of the Tongan individuals can be inferred from joint lesions 
indicating osteoarthritis (Table S1).
In Vanuatu, an archipelago western to Tonga, previous reports of most likely diagnoses of scurvy due to 
vitamin C  deficiencies95, gouty arthritis and  DISH11,12, point to significant metabolic and nutritional issues 
afflicting Pacific Islanders thousands of years ago. While we cannot provide one aetiological explanation for the 
occurrence of bone metabolic conditions in our sample, we propose that a combination of lifestyle factors such 
as nutrition, and genetic predisposition played a role in the poor Tongan bone metabolism. Theoretical attempts 
to explain the high incidence of metabolic disease in the Pacific have predominantly focused on genetics  (see98,99 
for discussion). “The Thrifty Genotype” hypothesis proposes that thrifty genes, which would have been advanta-
geous during famine events in the human past, drive diabetes and obesity in modern  environments99. However, 
considering our data, and the aforementioned archaeological skeletal data from other sites in the  region11,12,91–95, 
it is clear that genes alone cannot elucidate the human obesity trends in the Pacific. Additionally, as noted previ-
ously by Gosling et al98, thrifty genes cannot alone account for a range of selective pressures that characterised 
the Pacific islands. Alternative, or complementary, interpretations to consider include early childhood exposure 
to other  diseases91,92,100, compromising adult immunity which can equally result in altered bone turnover and 
poor skeletal  mineralisation100,101. Ongoing macroscopic pathology examination of the Talasiu sample will pro-
vide further data and help shed light on possible incidence of conditions such as DISH or gout, expanding our 
reported microscopic bone loss markers.
Table 2.  Histomorphometry and synchrotron source Fourier-transform infrared microspectroscopy 
descriptive data per estimated sex (four males and four females). SD: standard deviation, min.: minimum data, 
max.: maximum data, A-P: antero–posterior, M-L: medio-lateral, H.Dn: Haversian canal density per  mm2, 
%Po.Ar: percent area of sample impacted by porosity producing trabecularisation.
Estimated sex N Min Max Mean SD
Femur size and quantitative histology
Female
A-P midshaft diameter (mm) 4 25.28 29.30 27.26 2.15
M-L midshaft diameter (mm) 4 23.26 26.54 24.51 1.54
Midshaft circumference (mm) 4 76.00 86.00 79.75 4.79
H.Dn (/mm2) 4 12.216 22.223 15.60 4.54
%Po.Ar 4 13.908 50.232 35.508 16.397
Male
A-P midshaft diameter (mm) 4 27.72 33.87 30.75 2.87
M-L midshaft diameter (mm) 4 22.17 29.27 26.42 3.02
Midshaft circumference (mm) 4 86.00 101.00 92.25 7.09
H.Dn (/mm2) 4 15.63 20.80 17.45 2.295
%Po.Ar 4 0.000 51.793 15.813 24.171
Fourier-transform infrared microspectroscopy
Female
Peak phosphate height 848 0.201 1.139 0.481 0.189
Phosphate integrated area 848 15.087 71.381 34.518 11.673
Carbonate v2 height 1676 0.001 0.216 0.023 0.018
Carbonate v2 integrated area 2159 0.001 2.899 0.392 0.327
Carbonate v3 height 1676 0.001 0.050 0.011 0.008
Carbonate v3 integrated area 2071 0.001 2.873 0.475 0.498
Carbonate v2: phosphate ratio 846 0.001 0.143 0.019 0.007
Male
Peak phosphate height 2496 0.200 1.156 0.494 0.171
Phosphate integrated area 2496 14.937 72.184 34.899 10.346
Carbonate v2 height 3339 0.001 0.104 0.033 0.017
Carbonate v2 integrated area 3339 0.003 1.625 0.576 0.303
Carbonate v3 height 3329 0.001 0.352 0.017 0.011
Carbonate v3 integrated area 3264 0.001 8.510 0.850 0.526
Carbonate v2: phosphate ratio 2495 0.001 0.038 0.020 0.003
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Sex-specific and ageing driven bone fragility. Osteoporosis has a long history of afflicting females 
more than males due to menopause-driven loss of  estrogen31,32. Oestrogen plays a key role in inhibiting oste-
oclast-mediated bone resorption, by regulating osteoclast  apoptosis31. After menopause, prolonged bone loss 
occurs leading to increasingly porous and weak bones. Females are biologically disadvantaged because of this 
phenomenon, with modern postmenopausal women experiencing four times the level of osteoporosis than 
 men102. Our data for a sample of archaeological Tongan females appear to match this sex-specific difference 
in bone fragility, providing another line of interpretation as an alternative or complementary aetiology. All our 
female samples showed a trabecularisation effect whereby the compact bone exhibited trabeculae-like architec-
ture accompanied by cortical wall thinning (Figs. 1, 2). Female samples exhibiting higher cortical bone loss than 
male samples as a result of sex differences is consistent with prior  archaeological58 and clinical  reports103–105. The 
cortical wall bone not impacted by abnormal/trabecularised porosity in the female samples showed a lower den-
sity of Haversian canals, which can be interpreted as a proxy for the amount of remodelled  bone58,85. This can be 
explained by males possibly experiencing higher mechanically stimulated bone remodelling than females, body 
size differences, and/or within-sample age differences as noted in prior  studies73,103,104,106.
Inter-woven with the sex-specific differences in bone microstructure is  ageing65,72,103–105. It is well understood 
that the variability of age impacts on bone structure with sex manifests substantially in the femoral cross-section 
(and in other lower limb bones)107. Ageing of bone tissue results in a greater resorption on the endocortical 
surface, leading to modified long bone cross-sectional geometric  properties107. In a classic study examining 
this in a sample of US human  cadavers107, age-related endocortical resorption manifested both in males and 
females. However, males appeared to exhibit a simultaneous formation of bone sub-periosteally and resorp-
tion endo-cortically, which did not drastically impact bone  strength107. In females, while the medullary cavity 
expanded, there was no associated expansion of the sub-periosteal bone, meaning that their cross-sectional 
properties weakened with  age107. When considering preindustrial humans such as the Pecos who undertook 
high levels of physical  activity108, sex-differences in bone loss while present were not as extensive as those seen 
in the aforementioned  cadavers107. In the Pecos, sub-periosteal bone and biomechanical properties of the femur 
(and tibia) followed a general pattern of increase with age in both  sexes108. We were not able to undertake a 
biomechanical analysis of cross-sectional geometry, but the substantial thinning of cortical wall in the Tongan 
female samples, along with lower Haversian canal densities, could suggest not enough mechanically stimulated 
bone remodelling around the time of their peak bone mass accrual phase of the life-course (third life decade)109. 
Indeed, sedentary lifestyles are so widespread in Tonga today that several modern intervention efforts targeting 
adolescents have been  unsuccessful110. This raises an important consideration for future studies of archaeological 
bone loss comparing populations from different parts of the world, whereby environmental and lifestyle factors 
impacting bone building in the early ontogeny will differ in accordance to genetic and cultural  determinants109.
One of the negative repercussions of overall ‘improved’ longevity and mortality across contemporary human 
populations is the advanced age of soft and hard tissues that results in multiple degenerative diseases experienced 
by the  elderly111. Bone fragility, increased fracture incidence, and hip-replacement surgeries, are some of the 
most common issues for the elderly of significantly deteriorated skeletal health. One of our female individuals 
(ID: Sk3.1) showed highly advanced skeletal deterioration characteristics (e.g. loss of all mandibular teeth ante-
mortem, Figure S2) so she was classified as the oldest, and likely the only elderly, individual in our sample. This 
implies she might have survived into her sixth life decade (and possibly beyond). The combined age-at-death 
data and her abnormal intra-cortical porosity, are evidence that, at least some, archaeological Tongan females 
might have well surpassed the commonly assumed short longevity of humans in the distant  past112,113. The 
trabecularisation of the cortical bone in our samples is remarkably similar to histology and microradiography 
images of midshafts examined in modern Australians aged 89 year  old88, and 67, 78, 90 year  old114. This encour-
ages further research combining bone biology, skeletal anatomy, archaeology, and social structures of Tonga to 
elucidate aspects of care of elderly in past  Polynesia115.
Archaeological context-specific and methodological limitations of our study mean we cannot provide a 
single diagnosis and aetiology of the bone loss characteristics reported. Access to hundreds of well-preserved 
skeletons, as has been the case in some prior archaeological osteoporosis  studies54,55, is not possible at Talasiu 
as the site is on a remote island constrained by its land and population size. Given the archaeological age of the 
Talasiu samples, the preservation of bone is not comparable to modern or post-mortem tissue, and thus cannot 
be experimentally examined to the same level. Future microscopic research applied to archaeological human 
remains from the Pacific will hopefully generate more comparative data, ideally using complementary 3D and 2D 
methods where feasible. While our study is limited by the broad age-at-death ranges, this is an issue impossible 
to overcome in biological anthropology as a narrow and exact chronological age for archaeological individuals 
cannot be ascertained from gross osteological analysis  alone116. The assignment of biological sex is also a prob-
ability estimate based on well-established sexually dimorphic features of the human skeleton, which, without 
future aDNA validation, will be the best sex estimate possible.
Conclusions
Our results are the first microscopic record of cortical bone loss in a sample of archaeological humans from 
Tonga. Given the small sample size, we suggest caution in the generalisation of our results in regards to the wider 
archaeological Tongan societies. With larger archaeological samples from across the Pacific islands, a pattern in 
bone loss may be shown in the future. Nevertheless, our results are evidence that a possible occurrence of bone 
metabolic conditions in a sample of archaeological Pacific individuals can be detected microscopically. We think 
this is an important step forward for discussions about metabolic diseases in the past and present Pacific. We 
discussed several explanations for the observed bone loss markers including: sex-specific driven bone micro-
architectural deterioration with the possibility of our sample of Tongan females experiencing hormonal changes 
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due to menopause; age-related bone loss similar to that seen in modern aging populations; and lifestyle factors 
such as poor physical activity and nutrition. Equally, other diseases in the region compromising immunity might 
have contributed to abnormal bone physiology in our sample. Given how commonplace contemporary metabolic 
issues, including obesity and diabetes, are in Tonga, our key interpretation is that similar problems might have 
led to osteoporosis in our sample there ca. 3,000 years ago.
Methods
We implemented an invasive methodology and so were restricted to eight femora (seven right and one left) 
(Table 1). The choice of femur side was determined on the basis of macroscopic preservation and availability of 
midshaft bone for extraction. Brief summarises of gross anatomically visible skeletal lesions per individual are 
reported in Table S1, with several individuals (6/8) showing evidence for osteoarthritis. While limited, this sample 
size is comparable to previous research implementing microscopic methods of bone assessment in archaeological 
 samples77,85. The biological sex of the individuals represented by the femora had been previously  estimated82,83 
following established  methods117. Four males and four females (including one probable male and two probable 
females, Table 1) were estimated. The inclusion of ‘probable’ sexes is standard practice where archaeological 
human remains that do not show a directional consistency in sexually dimorphic skeletal  features119. The adult 
age-at-death was assigned based on morphological features of the pelvic auricular  surface118. The true chrono-
logical age of these individuals cannot be ascertained from bone morphology alone.
The skeletal remains represented by the specimens reported here were excavated and analysed with the per-
mission from the Lapaha Community and Nobles, and the Ministry of Internal Affairs (Government of Tonga). 
The samples are curated at the Australian National University, Canberra until further repatriation notice. Talasiu 
on Tongatapu in the Kingdom of Tonga is one of the most archaeologically significant sites in Asia–Pacific. It 
represents some of the earliest occupations of the Neolithic people migrating into the Pacific alongside the Lapita 
culture some 3200–2850 cal  BP120. It is a shoreline site located to the north of Lapaha, and is mainly comprised 
of shell middens and ceramic  deposits115. The first excavation of Talasiu had taken place in 1957 which was 
subsequently followed by dating of the recovered shellfish to 2800 + /− 70  BP120. Excavations from 2008 onwards 
revealed burials containing human remains, including burnt remains that provided an insight into early mortuary 
behaviours in the  region81. At least 19 late-Lapita/ immediately post-Lapita single to multiple burials have been 
reported, detailing a possible total number of 45 individuals represented and complex mortuary  practices81,82. 
Shell midden samples from Talasiu indicate a sedentary human occupation dated to approximately 2700–2650 cal 
 BP120, with more recent calibrations of 2650 BP for the  burials82. Twenty-one of these individuals were recently 
examined as part of a multi-isotopic analysis reconstructing the first Polynesian  diet83. A sub-sample of these 
Talasiu human individuals with well-preserved femora was studied here to conduct the analysis of bone loss 
markers. Applying the microscopic methods reported here to bones previously sampled for isotopic analysis, 
and limiting sample extraction to a cortical quadrant (rather than a complete long bone cross-section) ensures 
minimal invasion of the archaeological human material as per ethical  recommendations76.
Samples were collected from the midshaft femur due to its biomechanical versatility, and prior published 
data reporting abnormal porosity occurring  there103,104. Prior to sampling, each femur was photographed and 
measured at midshaft using standard WorkZone calipers and a measure tape to obtain A-P and M-L diameters 
(in mm), and the midshaft circumference (in mm) (Table 1). As the femora were fragmented on the distal and 
proximal ends, we could not measure maximum femoral lengths (Fig. 1). However, the determination of the mid-
shaft location was easily achieved by locating the linea aspera, which is also the region from which samples were 
extracted (Fig. 1). This followed prior methods examining femur bone histology in archaeological  specimens75,85, 
and reports of increased porosity on the posterior aspect of the femur in modern  cadavers103. Approximately 
1 cm thick cortical quadrants were removed using a Dremel 200/2–30 Two-Speed Rotary Tool equipped with a 
rotary blade. Cutting was performed as per prior  methodologies121. The samples detached loosely after the blade 
had reached the medullary cavity having made two parallel longitudinal and transverse cuts on the bone exterior.
The preparation for three different microscopic analyses (2D histology, 3D confocal laser topography scan-
ning, sFTIRM, Fig. 1) included sequential partitioning of bone samples into slices. Using the Dremel blade, each 
sample was further cut in half to designate an approximately 0.5 cm thick bone section for confocal topography 
scanning. The remainder of the sample was embedded in Buehler epoxy resin to impregnate the internal bone 
structure for histology and sFTIRM. Using a Kemet MICRA CUT precision cutter equipped with a 150 mm dia-
mond blade, a ~ 150 μm thin slice of bone was removed from the embedded block and designated for sFTIRM. 
The remaining portion of the sample was set aside for histological preparation.
The preparation of thin sections followed standard methods applicable to archaeological human  bone75. The 
histology surface revealed by cutting on the low speed cutter was glued to a microscope glass slide using Stuk 
epoxy glue. It was further trimmed on the saw and ground using a series of silicon carbide pads until ~ 100 μm 
thickness was reached. The sections were then polished using Buehler MicroPolish alumina powder and cleared 
in an ultrasonic bath. This was followed by dehydration in ethanol, clearing using xylene, and mounting with 
cover slips. Imaging of the thin sections was undertaken using a high powered Olympus BX53 microscope, a 
DP74 camera, and associated Olympus cellSens Life Science Technology software. Images were scanned under 
a 40 × total magnification (17 mm working distance) and ‘auto-stitched’ using the “Multiple Image Alignment—
MIA” tool available from the Olympus cellSens software. Each image was then imported into Adobe Photoshop 
CC 2014 (replicated recently in Photoshop CC 2020), greyscaled (Black & White), converted to type 16 bit, and 
thresholded so that Haversian canals throughout cortical bone were ‘enhanced’. This essentially converted cortical 
bone areas into black pixels and porous bone space into empty/white areas of the image (Fig. 2). Thresholding 
greyscale images for microscopic quantitative analysis is common  practice122,123 and can be applied to threshold 
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out Haversian  canals124. The images were imported into the open access ImageJ vol. 1.52 software for measure-
ments of quantifiable components of the thin sections.
In order to differentiate between porosity producing trabecularisation and Haversian canal density the sec-
tions had to be manually segmented. We followed descriptions  in88,89 where a delimitation between ‘dense’ 
cortical bone and porosity producing trabecularisation cortical space can be estimated by visually separating the 
two bone matrices (see red dashed line in Fig. 2). As such, five variables as reported in previous bone porosity 
 studies123–126 (some acronyms were modified following the nomenclature standards by Dempster et al127) were 
collected. Total Bone Area (T.B.Ar in  mm2)123 was measured using the ImageJ vol. 1.52 “Polygon” tool by tracing 
the outer outline endosteal and periosteal borders of the section. Porosity Area (Po.Ar in  mm2)124 was measured 
using the same tools, but by manually selecting intra-cortical bone regions characterised with abnormal ‘giant 
pores’ that originated from within the endo-cortical section areas, which we here define as porosity producing 
trabecularisation. Cortical area (Ct.Ar) was the cortical bone region comprising cortical walls where no porosity 
producing trabecularisation (Po.Ar) was noted (Ct.Ar = T.B.Ar – Po.Ar). From these measurements, we calculated 
porosity producing trabecularisation (%Po.Ar = P.Ar/T.B.Ar × 100). Therefore, if no trabecularised regions are 
consistently observed, this method allows for a null result of Po.Ar and %Po.Ar. From within the Ct.Ar, Haversian 
canal number (H.N) was counted  manually125,126 (using the “Multi-Point” tool in ImageJ vol. 1.52 see red dots in 
Fig. 1). To estimate Haversian canal density (H.Dn)125,126, H.N was divided by Ct.Ar to obtain a value per  mm2. 
Therefore, we took into consideration two types of bone porosity measures—H.Dn as a proxy for the amount of 
remodelled bone present in cortical bone, and %Po.Ar which estimates the area of intra-cortical bone affected by 
trabecularised cortex. Through H.Dn, we worked with an assumption that one Haversian canal represents one 
secondary osteon. Because cement lines of secondary osteons were not consistently preserved in these archaeo-
logical samples, this technique does not account for fragmentary osteons (Fig. 2). The canals that were counted 
were identified as Haversian canals to the best of our expertise. This excluded micro-features that resembled 
other pores, which might have occurred as a result of diagenesis. That way, %Po.Ar is exclusively composed of 
‘giant’ and coalescing pores, occurring consistently intra-cortically, originating on the endo-cortical part of the 
sample. These regions should otherwise be filled with dense cortical bone if the individual did not experience 
significant bone loss. Both measures can provide an insight into a Bone Multi Cellular unit (BMU) activity tun-
nelling through cortical  bone128, whereby H.Dn approximates the number of BMUs that once existed per  mm2, 
and %Po.Ar indicates prolonged bone resorption through osteoclast-mediated activity.
To provide a qualitative illustration of bone surface topography in relation to the porosity producing trabecu-
larisation, we scanned two contrasting male and female samples (IDs: Sk3.1 and Sk3.2) using an OLS5000 3D 
laser confocal microscope. Confocal laser scanning microscopy is a recommended technique for characteris-
ing porous structures such as  bones129. The associated OLS5000 2017 LEXT data acquisition and data analysis 
application software (Olympus LEXT, Japan) (Fig. 1) was then used to apply a heat map of false colours that 
ranged from red to blue indicating highest to lowest depth, respectively (Fig. 3, S10). This resulted in yellow to 
green colours indicating low topography (Fig. 3, S11) in the male, and red to blue marking high topography in 
the female (Fig. 3, S10). We used a 5 × LEXT short working distance objective (20 mm) with a 405 nm violet laser 
that scans 4,096 pixels along the x-axis, with the zoom as at 1.0x. We used the LEXT automated stitching tool to 
collectively scan six regions of bone located on the mid-line of the cortical area of the posterior bone quadrant. 
The scanned area of the female sample was 7192.648 μm long (y-axis) and 4872.699 μm wide (x-axis). The area 
scanned on the male sample was 7185.926 μm long (y-axis) and 4876.763 μm wide (x-axis). The z-plane depth 
(height of laser reaching the bone surface) was approximately 3741.925 μm.
Each sample was examined for phosphate and carbonate content using  sFTIRM86,130–136. Phosphate was 
selected because it is necessary for bone metabolism, and occurs in skeletal tissue as part of hydroxyapatite 
 crystals134. Carbonates (v2 and v3) substitute calcium apatite and influence the properties of crystal in bone, and 
thus influence bone function at the macroscopic  scale133. Carbonate in bone is mainly A-type whereby it substi-
tutes for phosphate, but it can also be naturally accompanied by B-type (substituting for hydroxide)133. Assessing 
total (A- and B-type combined) carbonate content, in addition to phosphate, and v2 carbonate and phosphate 
ratio of integrated areas under trace, can thus provide an insight into the extent to which calcium phosphate has 
been resorbed through osteoclast-mediated  activity86,135,136.
The samples were scanned at the IRM beamline at the Australian Synchrotron facility in Melbourne (Victoria). 
The scanning technique followed settings reported by Vrahnas et al.86 with the exception that we used an attenu-
ated total reflectance (ATR) attachment that allowed a direct contact with bone  surface85,87. The synchrotron 
light source provides a highly intense infrared beam that was used to analyse mineral content of bone in situ 
and the ATR attachment allows the collection of infrared (IR) data from sample sections that are otherwise too 
thick for conventional IR transmission  analysis87. The sFTIRM measurement was performed using a Bruker 
V80v FTIR spectrometer and a Hyperion 3000 IR microscope, which produced high quality spectra in terms of 
signal-to-noise ratios at 1–2 μm spatial resolution when the synchrotron IR beam coupled to the ATR  crystal87.
Each sample had four regions of interest (ROIs) identified on the sub-periosteal area of bone, avoiding the 
endocortical surfaces particularly that they are so extensively affected by abnormal porosity in the Talasiu samples 
(Fig. 1). Before placing the samples on the microscope stage, the ROIs were identified from images captured at 
2 × magnification under a basic dissecting microscope (Fig. 1). We measured carbonates v2 (890–850 cm−1) and v3 
(1500–1400 cm−1), and phosphate (1180–916 cm−1), which were then used to calculate carbonate(v2):phosphate 
ratios (890–850 cm−1:1180–916 cm−1)85,86,132,133. Data analysis was undertaken in OPUS 7.2 and 8.0.19 (Bruker 
Optik, Germany) by creating integration files and extracting peak height (absorbance/AU) and area under the 
trace values in each spectrum. Each ROI was scanned for 220 spectra, which totalled 880 spectra per sample, 
totalling 6820 spectra in the entire sample (this excludes the second region of interest, which was unsuccessfully 
scanned, therefore deducting 220 spectra in data for individual Sk 3.1).
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Once data were inspected, it became apparent that not all spectra were suitable for analysis. This might have 
occurred as a result of the ATR attachment not making contact with all scanned bone regions. Additionally, as 
our samples derive from an archaeological context, and are thus impacted by diagenetic processes, diagenetic 
calcite deposited post-mortem can contribute to carbonate sites of the spectra. To account for these issues, the 
spectra were inspected and those of poor quality were removed. Our supplemental file (Dataset S1) with raw 
data reports all spectra collected during the scanning, as well as the datasets following inspection. The inspec-
tion involved removing phosphate peak values (and corresponding integrated areas under the peak) of < 0.2. 
All carbonate spectra values in the negative range to 0.001 were also removed. To further assess for possible 
diagenesis impacting the carbonate data (sites where calcite can occur), statistical correlations were performed to 
check how well carbonate v2 and v3 data aligned within each specimen (Table S6, S7). Where no strong correla-
tions were identified, this was taken as an indication that diagenesis might have impacted the data as v3 and v2 
values are scattered randomly. We also visually examined the sites of v3 for a strong peak at 1427 cm−1 indicating 
presence of calcite, which should otherwise be replaced by a trough in apatite spectra (creating a doublet)137 
(Figure S3–S9). Overall, the inspection reduced the number of suitable phosphate spectra to 3344 in males and 
844 in females. Carbonate spectra were minimum 1676 (v2) and 2159 (v3) in females, and 3339 (v2) and 3329 
(v3) in males (Table 2). The carbonate v2:phosphate ratios calculated from integrated areas under the trace were 
possible to compute for 846 in females and 2495 in males. We note that all data for Sk12 appeared unsuitable, 
and so this specimen was excluded from data comparisons.
All data obtained in our study were firstly summarised descriptively. Descriptive comparisons were made 
within-sample by contrasting results between the sexes, and identifying whether either of the groups showed 
relatively higher or lower values of data. Next, as our sample size is small (n = 8), we were limited in the choice 
of statistical analyses to conduct inferential tests. On this basis, we applied non-parametric tests when compar-
ing the sex groups (using a Mann Whitney U  test138) and a Spearman’s Rho correlation to test if %Po.Ar was 
significantly associated with cortical thinning. All inferential statistical testing was conducted in IBM Statistical 
Package for Social Sciences 26 (SPSS) software. For the sFTIRM spectra inspection through correlations, data 
normality Kolmogorov–Smirnov tests were performed to check whether non-parametric or parametric correla-
tions tests should be applied (Table S7). This step informed the use of Spearman’s Rho correlations as the spectra 
values were not normally distributed (Table S7, S8). Strong correlations (Rho = 0.68–1.00)139 were taken as an 
indication that data can be interpreted to draw conclusions for our research question.
Data availability
All data generated or analysed during this study are included in this published article (and its Supplementary 
Information files).
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